Issue Information.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 1, doi. 10.1002/phar.1999
- Publication type:
- Article
Works matching IS 02770008 AND DT 2018 AND VI 38 AND IP 1
Results: 16
1
2
A Watershed Outlook for Pharmacotherapy in 2018.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 4, doi. 10.1002/phar.2072
- By:
- Publication type:
- Article
3
The Philosophy of Practice for Comprehensive Medication Management: Evaluating Its Meaning and Application by Practitioners.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 69, doi. 10.1002/phar.2062
- By:
- Publication type:
- Article
4
Therapeutic Benefit of Smoked Cannabis in Randomized Placebo‐Controlled Studies.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 80, doi. 10.1002/phar.2064
- By:
- Publication type:
- Article
5
Severe Hypoglycemia Caused by Lenalidomide.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. e1, doi. 10.1002/phar.2061
- By:
- Publication type:
- Article
6
Ketamine for the Acute Management of Excited Delirium and Agitation in the Prehospital Setting.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 139, doi. 10.1002/phar.2060
- By:
- Publication type:
- Article
7
Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the Treatment of Native Glomerular Disease.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 51, doi. 10.1002/phar.2059
- By:
- Publication type:
- Article
8
Community Health Workers Supporting Clinical Pharmacists in Diabetes Management: A Randomized Controlled Trial.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 58, doi. 10.1002/phar.2058
- By:
- Publication type:
- Article
9
Multiple‐Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated Infections.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 152, doi. 10.1002/phar.2057
- By:
- Publication type:
- Article
10
Medication Management of Patients Undergoing Transcatheter Aortic Valve Replacement.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 122, doi. 10.1002/phar.2056
- By:
- Publication type:
- Article
11
Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 86, doi. 10.1002/phar.2055
- By:
- Publication type:
- Article
12
Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram‐Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 42, doi. 10.1002/phar.2054
- By:
- Publication type:
- Article
13
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 29, doi. 10.1002/phar.2051
- By:
- Publication type:
- Article
14
What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 108, doi. 10.1002/phar.2050
- By:
- Publication type:
- Article
15
Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 6, doi. 10.1002/phar.2046
- By:
- Publication type:
- Article
16
Observational Comparative Effectiveness of Pharmaceutical Treatments for Obesity within the Veterans Health Administration.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 1, p. 19, doi. 10.1002/phar.2048
- By:
- Publication type:
- Article